Evidence map›Paper›PMID 40868819›Full record

ArticleLife (Basel, Switzerland)2025

Association of

Daniel Vázquez-Coto, Marta García-Clemente, Guillermo M Albaiceta, Laura Amado, Lorena M Vega-Prado, Claudia García-Lago, Rebeca Lorca, Juan Gómez, Eliecer Coto

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel Vázquez-CotoGenética Molecular, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Marta García-ClementeNeumología, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Guillermo M AlbaicetaInstituto de Investigación Sanitaria del Principado de Asturias, ISPA, 33011 Oviedo, Spain.
Laura AmadoInstituto de Investigación Sanitaria del Principado de Asturias, ISPA, 33011 Oviedo, Spain.ORCID 0000-0002-8793-0213
Lorena M Vega-PradoGenética Molecular, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Claudia García-LagoInstituto de Investigación Sanitaria del Principado de Asturias, ISPA, 33011 Oviedo, Spain.
Rebeca LorcaMedicine Department, Universidad de Oviedo, 33011 Oviedo, Spain.
Juan GómezGenética Molecular, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-3318-4649
Eliecer CotoGenética Molecular, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-8649-9150

Funding

Gobierno del Principado de Asturias FICYT-AYUD/2021/520148 (G.M.A).Instituto de Salud Carlos III (ISCIII) FI-23/00207 (DVC)Instituto de Salud Carlos III (ISCIII) PI-21/00971 (EC)Instituto de Salud Carlos III (ISCIII) PI-22/00705 (JG)Instituto de Salud Carlos III (ISCIII) RICORS2040-RD21/005 (EC)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19gene polymorphismsRNA vaccinesSTING1

Identifiers

PMID40868819
PMCPMC12387892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.